Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 2

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 2
---
 Pledging Policy                                                |   55 |
| RELATED PERSON RELATIONSHIPS AND TRANSACTIONS                                   |   56 |
| Introduction                                                                    |   56 |
| Description of Related Party Transactions                                       |   56 |
| Policies and Procedures for Related Party Transactions                          |   57 |
| SHAREHOLDER PROPOSALS FOR THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS       |   59 |
| COPIES OF FISCAL 2024 ANNUAL REPORT AND ADDITIONAL INFORMATION                  |   60 |

DiaMedica Therapeutics Inc. is sometimes referred to as “DiaMedica,” “we,” “our” or “us” in this proxy statement.

The 2025 Annual General Meeting of Shareholders is sometimes referred to as the “Annual General Meeting,” “Annual Meeting” or “meeting” in this proxy statement.

Our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 is sometimes referred to as our “Annual Report to Shareholders” or “2024 Annual Report” in this proxy statement.

Our voting common shares, no par value, are sometimes referred to as our “common shares” or “shares” in this proxy statement.

All dollar amounts in this proxy statement are expressed in United States currency unless otherwise noted.

<div align='center'>ii

PROXY STATEMENT SUMMARY</div>

This summary provides an overview of the information included in this proxy statement. We recommend that you review the entire proxy statement and our Annual Report to Shareholders before voting.

2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS

| DATE AND TIME                                                                                                                                                           
 Thursday, May 15, 2025                                                                                                                                                  
 9:00 a.m. (CDT)                                                                                                                                                         
 LOCATION                                                                                                                                                                
 DiaMedica Therapeutics Inc.                                                                                                                                             
 301 Carlson Parkway, Suite 210,                                                                                                                                         
 Minneapolis, Minnesota 55305                                                                                                                                            
 RECORD DATE                                                                                                                                                             
 Holders of record of our common shares at the close of business on March 18, 2025 are entitled to notice of, to attend, and to vote at the 2025 Annual General Meeting. |                                                                                                    | Voting Item |   Board’s Vote 
 Recommendation | Page |
|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:---------------------------------------------------------------------------------------------------|:------------|---------------:|:-----|
|                                                                                                                                                                         | Voting Proposal One:                                                                               
 Election of Directors                                                                              | FOR         |             10 |      |
|                                                                                                                                                                         | Voting Proposal Two:                                                                               
 Appointment of Independent Registered